Newport Biotech Consultants

Dr. John Morrow and Attorney Lance Anderson discuss biotechnology law in Austin TX

Dr. Chris Mayhew and technician Amy Pitstick of Cincinnati Children's Hospital

John Morrow and Matt Gaevert discuss Kiyatec's 3D culture technology

Discussing climate change at University of Cincinnati

Morrow and Mayhew consider stem cell technology at Cincinnati Children's

A visit to Biologic Covington KY

Morrow discussing Bexion technology with Dr. Neil Chaudhary

Discussing protein characterization assays at Bexion

Morrow meets with Paul Davis, CEO Quanta Biodesign

With Ray Takigiku, CEO Bexion Pharma

with Cheng Liu, CEO Eureka Pharma

Sartorius Conference, Gottingen, Germany with Bettina Berendsen, VP sales

with Susan Luken, Sinclair College Biotech

Performance exceeding expectations.

Newport Biotechnology Consultants serves the life sciences industry providing research, writing, business planning and emergency management solutions.  Founder Dr. K. John Morrow Jr. (President/CEO) draws upon academic and industrial experience to cover new developments and technologies in antibody therapeutics and related areas of biotechnology. With an extensive list of publications in trade and peer-reviewed journals, we are prepared to evaluate business plans, prepare technical reports and develop advertising literature. To download some of my latest publications go to "Who We Are" page.

 

A range of quality services

  • Writing expertise
    • life sciences industry
    • specialization in molecular immunology
  • Coverage of new developments and technologies
  • Emergency management
  • Bio-Safety Consulting
  • Business plan evaluation.
  • Translation, Interpretation   (English/Italian) 
  • Recently coedited with Cheng Liu: "Biosimilars of Monoclonal Antibodies" Wiley Publishers

View all Services

Recent Blog Entries

Bioweapons: An Existential Threat?

March 6, 2017

With the rise and widespread dissemination of CRISPR technology, new concerns have been voiced over the possible applications of these technologies to the facile development of a new generation of potent biological weapons against which there would...

Read More
*